Sanofi (SNY) Shares Outstanding (Weighted Average) (2016 - 2025)
Sanofi's Shares Outstanding (Weighted Average) history spans 9 years, with the latest figure at $1.4 billion for Q4 2025.
- For Q4 2025, Shares Outstanding (Weighted Average) rose 6.23% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 6.23%, while the annual FY2025 figure was $1.4 billion, 1.8% up from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 was $1.4 billion at Sanofi, up from $1.3 billion in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $1.4 billion in Q4 2021 and bottomed at $1.3 billion in Q4 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $1.3 billion (2023), against an average of $1.4 billion.
- The largest annual shift saw Shares Outstanding (Weighted Average) dropped 10.86% in 2022 before it grew 6.23% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.4 billion in 2021, then fell by 10.86% to $1.3 billion in 2022, then grew by 5.44% to $1.3 billion in 2023, then dropped by 0.71% to $1.3 billion in 2024, then rose by 6.23% to $1.4 billion in 2025.
- Per Business Quant, the three most recent readings for SNY's Shares Outstanding (Weighted Average) are $1.4 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.3 billion (Q4 2023).